Listed

Amneal Pharmaceuticals, Inc.

AMRXNasdaqCIK 1723128HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$796.2m, Q2 FY2026
Operating income$129.8m, Q2 FY2026
Net income$57.7m, Q2 FY2026
Amneal Pharmaceuticals, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m620Revenue, Q3 FY2023, three months to 2023-09-30$620.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-12, accession 0001723128-24-000042.Report this figure617Revenue, Q4 FY2023, three months to 2023-12-31$617.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001723128-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure659Revenue, Q1 FY2024, three months to 2024-03-31$659.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-07, accession 0001723128-25-000022.Report this figure702Revenue, Q2 FY2024, three months to 2024-06-30$701.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0001723128-25-000047.Report this figure702Revenue, Q3 FY2024, three months to 2024-09-30$702.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001723128-25-000062.Report this figure731Revenue, Q4 FY2024, three months to 2024-12-31$730.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001723128-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure695Revenue, Q1 FY2025, three months to 2025-03-31$695.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure725Revenue, Q2 FY2025, three months to 2025-06-30$724.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure785Revenue, Q3 FY2025, three months to 2025-09-30$784.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001723128-25-000062.Report this figure814Revenue, Q4 FY2025, three months to 2025-12-31$814.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001723128-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure723Revenue, Q1 FY2026, three months to 2026-03-31$722.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure796Revenue, Q2 FY2026, three months to 2026-06-30$796.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure
Cost of revenue$m388Cost of revenue, Q3 FY2023, three months to 2023-09-30$387.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-12, accession 0001723128-24-000042.Report this figure427Cost of revenue, Q4 FY2023, three months to 2023-12-31$427.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-27, accession 0001723128-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure421Cost of revenue, Q1 FY2024, three months to 2024-03-31$421.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-07, accession 0001723128-25-000022.Report this figure452Cost of revenue, Q2 FY2024, three months to 2024-06-30$451.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-07, accession 0001723128-25-000047.Report this figure433Cost of revenue, Q3 FY2024, three months to 2024-09-30$432.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-06, accession 0001723128-25-000062.Report this figure468Cost of revenue, Q4 FY2024, three months to 2024-12-31$467.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-27, accession 0001723128-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure440Cost of revenue, Q1 FY2025, three months to 2025-03-31$439.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure438Cost of revenue, Q2 FY2025, three months to 2025-06-30$438.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure511Cost of revenue, Q3 FY2025, three months to 2025-09-30$510.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-06, accession 0001723128-25-000062.Report this figure517Cost of revenue, Q4 FY2025, three months to 2025-12-31$517.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-27, accession 0001723128-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure402Cost of revenue, Q1 FY2026, three months to 2026-03-31$402.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure462Cost of revenue, Q2 FY2026, three months to 2026-06-30$461.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure
Gross profit$m233Gross profit, Q3 FY2023, three months to 2023-09-30$232.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-12, accession 0001723128-24-000042.Report this figure190Gross profit, Q4 FY2023, three months to 2023-12-31$189.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-27, accession 0001723128-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure238Gross profit, Q1 FY2024, three months to 2024-03-31$238.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-07, accession 0001723128-25-000022.Report this figure250Gross profit, Q2 FY2024, three months to 2024-06-30$249.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-07, accession 0001723128-25-000047.Report this figure270Gross profit, Q3 FY2024, three months to 2024-09-30$269.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0001723128-25-000062.Report this figure263Gross profit, Q4 FY2024, three months to 2024-12-31$262.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-27, accession 0001723128-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure256Gross profit, Q1 FY2025, three months to 2025-03-31$255.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure286Gross profit, Q2 FY2025, three months to 2025-06-30$286.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure274Gross profit, Q3 FY2025, three months to 2025-09-30$274.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0001723128-25-000062.Report this figure297Gross profit, Q4 FY2025, three months to 2025-12-31$297.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-27, accession 0001723128-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure320Gross profit, Q1 FY2026, three months to 2026-03-31$320.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure335Gross profit, Q2 FY2026, three months to 2026-06-30$334.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure
Research and development$m41.4Research and development, Q3 FY2023, three months to 2023-09-30$41.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0001723128-24-000042.Report this figure46.1Research and development, Q4 FY2023, three months to 2023-12-31$46.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-27, accession 0001723128-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure39.3Research and development, Q1 FY2024, three months to 2024-03-31$39.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-07, accession 0001723128-25-000022.Report this figure36.1Research and development, Q2 FY2024, three months to 2024-06-30$36.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0001723128-25-000047.Report this figure61.1Research and development, Q3 FY2024, three months to 2024-09-30$61.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001723128-25-000062.Report this figure54.3Research and development, Q4 FY2024, three months to 2024-12-31$54.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-27, accession 0001723128-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure40.0Research and development, Q1 FY2025, three months to 2025-03-31$40.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure48.0Research and development, Q2 FY2025, three months to 2025-06-30$48.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure63.4Research and development, Q3 FY2025, three months to 2025-09-30$63.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001723128-25-000062.Report this figure34.8Research and development, Q4 FY2025, three months to 2025-12-31$34.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-27, accession 0001723128-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure38.4Research and development, Q1 FY2026, three months to 2026-03-31$38.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure39.0Research and development, Q2 FY2026, three months to 2026-06-30$39.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure
Selling, general and administrative$m113Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$113.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-12, accession 0001723128-24-000042.Report this figure109Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$109.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-27, accession 0001723128-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure113Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$112.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-07, accession 0001723128-25-000022.Report this figure116Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$116.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-07, accession 0001723128-25-000047.Report this figure119Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$118.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001723128-25-000062.Report this figure129Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$128.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-27, accession 0001723128-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure118Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$118.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure124Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$124.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure138Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$137.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001723128-25-000062.Report this figure146Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$146.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-27, accession 0001723128-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure139Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$138.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure149Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$148.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure
Operating income$m75.6Operating income, Q3 FY2023, three months to 2023-09-30$75.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0001723128-24-000042.Report this figure14.2Operating income, Q4 FY2023, three months to 2023-12-31$14.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001723128-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(10.7)Operating income, Q1 FY2024, three months to 2024-03-31−$10.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-07, accession 0001723128-25-000022.Report this figure95.5Operating income, Q2 FY2024, three months to 2024-06-30$95.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0001723128-25-000047.Report this figure88.8Operating income, Q3 FY2024, three months to 2024-09-30$88.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001723128-25-000062.Report this figure75.8Operating income, Q4 FY2024, three months to 2024-12-31$75.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001723128-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure100Operating income, Q1 FY2025, three months to 2025-03-31$100.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure111Operating income, Q2 FY2025, three months to 2025-06-30$111.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure70.3Operating income, Q3 FY2025, three months to 2025-09-30$70.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001723128-25-000062.Report this figure112Operating income, Q4 FY2025, three months to 2025-12-31$112.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001723128-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure142Operating income, Q1 FY2026, three months to 2026-03-31$141.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure130Operating income, Q2 FY2026, three months to 2026-06-30$129.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure
Income tax$m(2.1)Income tax, Q3 FY2023, three months to 2023-09-30−$2.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0001723128-24-000042.Report this figure9.9Income tax, Q4 FY2023, three months to 2023-12-31$9.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-27, accession 0001723128-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure6.2Income tax, Q1 FY2024, three months to 2024-03-31$6.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-07, accession 0001723128-25-000022.Report this figure3.6Income tax, Q2 FY2024, three months to 2024-06-30$3.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0001723128-25-000047.Report this figure3.7Income tax, Q3 FY2024, three months to 2024-09-30$3.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001723128-25-000062.Report this figure5.4Income tax, Q4 FY2024, three months to 2024-12-31$5.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-27, accession 0001723128-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure12.9Income tax, Q1 FY2025, three months to 2025-03-31$12.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure16.1Income tax, Q2 FY2025, three months to 2025-06-30$16.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure(23.4)Income tax, Q3 FY2025, three months to 2025-09-30−$23.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001723128-25-000062.Report this figure5.7Income tax, Q4 FY2025, three months to 2025-12-31$5.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-27, accession 0001723128-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure2.2Income tax, Q1 FY2026, three months to 2026-03-31$2.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure1.4Income tax, Q2 FY2026, three months to 2026-06-30$1.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure
Net income$m9.7Net income, Q3 FY2023, three months to 2023-09-30$9.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001723128-24-000042.Report this figure(98.6)Net income, Q4 FY2023, three months to 2023-12-31−$98.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001723128-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(91.6)Net income, Q1 FY2024, three months to 2024-03-31−$91.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-07, accession 0001723128-25-000022.Report this figure6.0Net income, Q2 FY2024, three months to 2024-06-30$6.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-07, accession 0001723128-25-000047.Report this figure(0.2)Net income, Q3 FY2024, three months to 2024-09-30−$156.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001723128-25-000062.Report this figure(31.1)Net income, Q4 FY2024, three months to 2024-12-31−$31.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001723128-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure12.2Net income, Q1 FY2025, three months to 2025-03-31$12.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure22.4Net income, Q2 FY2025, three months to 2025-06-30$22.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure2.4Net income, Q3 FY2025, three months to 2025-09-30$2.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001723128-25-000062.Report this figure35.1Net income, Q4 FY2025, three months to 2025-12-31$35.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001723128-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure62.3Net income, Q1 FY2026, three months to 2026-03-31$62.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure57.7Net income, Q2 FY2026, three months to 2026-06-30$57.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure
Diluted EPS$ per share0.06Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0001723128-24-000042.Report this figurenot reported(0.30)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-07, accession 0001723128-25-000022.Report this figure0.02Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0001723128-25-000047.Report this figure0.00Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001723128-25-000062.Report this figurenot reported0.04Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure0.07Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure0.01Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001723128-25-000062.Report this figurenot reported0.19Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure0.18Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure
Basic EPS$ per share0.06Basic EPS, Q3 FY2023, three months to 2023-09-30$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001723128-24-000042.Report this figurenot reported(0.30)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-07, accession 0001723128-25-000022.Report this figure0.02Basic EPS, Q2 FY2024, three months to 2024-06-30$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0001723128-25-000047.Report this figure0.00Basic EPS, Q3 FY2024, three months to 2024-09-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001723128-25-000062.Report this figurenot reported0.04Basic EPS, Q1 FY2025, three months to 2025-03-31$0.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure0.07Basic EPS, Q2 FY2025, three months to 2025-06-30$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure0.01Basic EPS, Q3 FY2025, three months to 2025-09-30$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001723128-25-000062.Report this figurenot reported0.20Basic EPS, Q1 FY2026, three months to 2026-03-31$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure0.18Basic EPS, Q2 FY2026, three months to 2026-06-30$0.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure

Balance sheet

Cash and equivalents$127.6m, Q2 FY2026
Long-term debt$2.56bn, Q2 FY2026
Shareholders' equity$33.0m, Q2 FY2026
Amneal Pharmaceuticals, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m86.9Cash and equivalents, Q3 FY2023, at 2023-09-30$86.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0001723128-24-000042.Report this figure91.5Cash and equivalents, FY2023, at 2023-12-31$91.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-27, accession 0001723128-26-000011.Report this figure46.5Cash and equivalents, Q1 FY2024, at 2024-03-31$46.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-07, accession 0001723128-25-000022.Report this figure43.8Cash and equivalents, Q2 FY2024, at 2024-06-30$43.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0001723128-25-000047.Report this figure74.0Cash and equivalents, Q3 FY2024, at 2024-09-30$74.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001723128-25-000062.Report this figure111Cash and equivalents, FY2024, at 2024-12-31$110.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-27, accession 0001723128-26-000011.Report this figure59.2Cash and equivalents, Q1 FY2025, at 2025-03-31$59.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure71.5Cash and equivalents, Q2 FY2025, at 2025-06-30$71.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure201Cash and equivalents, Q3 FY2025, at 2025-09-30$201.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001723128-25-000062.Report this figure282Cash and equivalents, FY2025, at 2025-12-31$282.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure198Cash and equivalents, Q1 FY2026, at 2026-03-31$197.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure128Cash and equivalents, Q2 FY2026, at 2026-06-30$127.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure
Current assets$m1,456Current assets, Q3 FY2023, at 2023-09-30$1.46bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0001723128-23-000044.Report this figure1,378Current assets, FY2023, at 2023-12-31$1.38bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-28, accession 0001723128-25-000012.Report this figure1,380Current assets, Q1 FY2024, at 2024-03-31$1.38bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-08, accession 0001723128-24-000021.Report this figure1,485Current assets, Q2 FY2024, at 2024-06-30$1.49bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-09, accession 0001723128-24-000032.Report this figure1,513Current assets, Q3 FY2024, at 2024-09-30$1.51bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001723128-24-000042.Report this figure1,588Current assets, FY2024, at 2024-12-31$1.59bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-27, accession 0001723128-26-000011.Report this figure1,510Current assets, Q1 FY2025, at 2025-03-31$1.51bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-07, accession 0001723128-25-000022.Report this figure1,585Current assets, Q2 FY2025, at 2025-06-30$1.58bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0001723128-25-000047.Report this figure1,838Current assets, Q3 FY2025, at 2025-09-30$1.84bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001723128-25-000062.Report this figure1,911Current assets, FY2025, at 2025-12-31$1.91bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure1,798Current assets, Q1 FY2026, at 2026-03-31$1.80bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure1,947Current assets, Q2 FY2026, at 2026-06-30$1.95bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure
Total assets$m3,687Total assets, Q3 FY2023, at 2023-09-30$3.69bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0001723128-23-000044.Report this figure3,473Total assets, FY2023, at 2023-12-31$3.47bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-28, accession 0001723128-25-000012.Report this figure3,456Total assets, Q1 FY2024, at 2024-03-31$3.46bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-08, accession 0001723128-24-000021.Report this figure3,510Total assets, Q2 FY2024, at 2024-06-30$3.51bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-09, accession 0001723128-24-000032.Report this figure3,461Total assets, Q3 FY2024, at 2024-09-30$3.46bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001723128-24-000042.Report this figure3,501Total assets, FY2024, at 2024-12-31$3.50bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-27, accession 0001723128-26-000011.Report this figure3,365Total assets, Q1 FY2025, at 2025-03-31$3.37bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-07, accession 0001723128-25-000022.Report this figure3,423Total assets, Q2 FY2025, at 2025-06-30$3.42bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0001723128-25-000047.Report this figure3,600Total assets, Q3 FY2025, at 2025-09-30$3.60bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001723128-25-000062.Report this figure3,678Total assets, FY2025, at 2025-12-31$3.68bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure3,540Total assets, Q1 FY2026, at 2026-03-31$3.54bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure3,776Total assets, Q2 FY2026, at 2026-06-30$3.78bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure
Current liabilities$m761Current liabilities, Q3 FY2023, at 2023-09-30$760.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0001723128-23-000044.Report this figure847Current liabilities, FY2023, at 2023-12-31$846.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-28, accession 0001723128-25-000012.Report this figure834Current liabilities, Q1 FY2024, at 2024-03-31$834.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-08, accession 0001723128-24-000021.Report this figure1,114Current liabilities, Q2 FY2024, at 2024-06-30$1.11bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-09, accession 0001723128-24-000032.Report this figure1,095Current liabilities, Q3 FY2024, at 2024-09-30$1.10bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0001723128-24-000042.Report this figure1,130Current liabilities, FY2024, at 2024-12-31$1.13bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-27, accession 0001723128-26-000011.Report this figure1,076Current liabilities, Q1 FY2025, at 2025-03-31$1.08bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-07, accession 0001723128-25-000022.Report this figure1,107Current liabilities, Q2 FY2025, at 2025-06-30$1.11bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0001723128-25-000047.Report this figure862Current liabilities, Q3 FY2025, at 2025-09-30$862.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001723128-25-000062.Report this figure882Current liabilities, FY2025, at 2025-12-31$881.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure728Current liabilities, Q1 FY2026, at 2026-03-31$728.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure883Current liabilities, Q2 FY2026, at 2026-06-30$883.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure
Total liabilities$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Long-term debt$m2,542Long-term debt, Q3 FY2023, at 2023-09-30$2.54bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-09, accession 0001723128-23-000044.Report this figure2,386Long-term debt, FY2023, at 2023-12-31$2.39bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-02-28, accession 0001723128-25-000012.Report this figure2,378Long-term debt, Q1 FY2024, at 2024-03-31$2.38bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-08, accession 0001723128-24-000021.Report this figure2,178Long-term debt, Q2 FY2024, at 2024-06-30$2.18bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-09, accession 0001723128-24-000032.Report this figure2,170Long-term debt, Q3 FY2024, at 2024-09-30$2.17bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-12, accession 0001723128-24-000042.Report this figure2,162Long-term debt, FY2024, at 2024-12-31$2.16bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-02-27, accession 0001723128-26-000011.Report this figure2,154Long-term debt, Q1 FY2025, at 2025-03-31$2.15bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-07, accession 0001723128-25-000022.Report this figure2,146Long-term debt, Q2 FY2025, at 2025-06-30$2.15bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-07, accession 0001723128-25-000047.Report this figure2,567Long-term debt, Q3 FY2025, at 2025-09-30$2.57bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-06, accession 0001723128-25-000062.Report this figure2,565Long-term debt, FY2025, at 2025-12-31$2.57bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure2,566Long-term debt, Q1 FY2026, at 2026-03-31$2.57bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure2,564Long-term debt, Q2 FY2026, at 2026-06-30$2.56bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure
Current portion of debt$m30.5Current portion of debt, Q3 FY2023, at 2023-09-30$30.5m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2023-11-09, accession 0001723128-23-000044.Report this figure34.1Current portion of debt, FY2023, at 2023-12-31$34.1m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-02-28, accession 0001723128-25-000012.Report this figure33.7Current portion of debt, Q1 FY2024, at 2024-03-31$33.7m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-05-08, accession 0001723128-24-000021.Report this figure225Current portion of debt, Q2 FY2024, at 2024-06-30$225.2m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-08-09, accession 0001723128-24-000032.Report this figure225Current portion of debt, Q3 FY2024, at 2024-09-30$224.7m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-11-12, accession 0001723128-24-000042.Report this figure224Current portion of debt, FY2024, at 2024-12-31$224.2m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-02-27, accession 0001723128-26-000011.Report this figure31.8Current portion of debt, Q1 FY2025, at 2025-03-31$31.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-05-07, accession 0001723128-25-000022.Report this figure31.2Current portion of debt, Q2 FY2025, at 2025-06-30$31.2m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-08-07, accession 0001723128-25-000047.Report this figure7.2Current portion of debt, Q3 FY2025, at 2025-09-30$7.2m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-11-06, accession 0001723128-25-000062.Report this figure6.8Current portion of debt, FY2025, at 2025-12-31$6.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure6.2Current portion of debt, Q1 FY2026, at 2026-03-31$6.2m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure6.0Current portion of debt, Q2 FY2026, at 2026-06-30$6.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure
Shareholders' equity$m331Shareholders' equity, Q3 FY2023, at 2023-09-30$330.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-11-09, accession 0001723128-23-000044.Report this figure19.8Shareholders' equity, FY2023, at 2023-12-31$19.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-02-28, accession 0001723128-25-000012.Report this figure(63.7)Shareholders' equity, Q1 FY2024, at 2024-03-31−$63.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-05-08, accession 0001723128-24-000021.Report this figure(57.5)Shareholders' equity, Q2 FY2024, at 2024-06-30−$57.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-08-09, accession 0001723128-24-000032.Report this figure(93.4)Shareholders' equity, Q3 FY2024, at 2024-09-30−$93.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0001723128-24-000042.Report this figure(109)Shareholders' equity, FY2024, at 2024-12-31−$109.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-27, accession 0001723128-26-000011.Report this figure(132)Shareholders' equity, Q1 FY2025, at 2025-03-31−$131.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-07, accession 0001723128-25-000022.Report this figure(112)Shareholders' equity, Q2 FY2025, at 2025-06-30−$112.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-07, accession 0001723128-25-000047.Report this figure(109)Shareholders' equity, Q3 FY2025, at 2025-09-30−$109.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001723128-25-000062.Report this figure(70.8)Shareholders' equity, FY2025, at 2025-12-31−$70.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure(45.4)Shareholders' equity, Q1 FY2026, at 2026-03-31−$45.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure33.0Shareholders' equity, Q2 FY2026, at 2026-06-30$33.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure

Cash flow

Operating cash flow−$21.2m, Q2 FY2026
Capital expenditure$30.7m, Q2 FY2026
Amneal Pharmaceuticals, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m81.4Operating cash flow, Q3 FY2023, three months to 2023-09-30$81.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001723128-24-000042. Derived: 9-month figure less the 6-month figure.Report this figure136Operating cash flow, Q4 FY2023, three months to 2023-12-31$135.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001723128-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(4.4)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$4.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-07, accession 0001723128-25-000022.Report this figure39.7Operating cash flow, Q2 FY2024, three months to 2024-06-30$39.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0001723128-25-000047. Derived: 6-month figure less the 3-month figure.Report this figure142Operating cash flow, Q3 FY2024, three months to 2024-09-30$141.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001723128-25-000062. Derived: 9-month figure less the 6-month figure.Report this figure118Operating cash flow, Q4 FY2024, three months to 2024-12-31$118.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001723128-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure7.4Operating cash flow, Q1 FY2025, three months to 2025-03-31$7.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure83.8Operating cash flow, Q2 FY2025, three months to 2025-06-30$83.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001723128-26-000031. Derived: 6-month figure less the 3-month figure.Report this figure118Operating cash flow, Q3 FY2025, three months to 2025-09-30$118.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001723128-25-000062. Derived: 9-month figure less the 6-month figure.Report this figure130Operating cash flow, Q4 FY2025, three months to 2025-12-31$130.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001723128-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(26.7)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$26.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure(21.2)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$21.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001723128-26-000031. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m11.7Capital expenditure, Q3 FY2023, three months to 2023-09-30$11.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0001723128-24-000042. Derived: 9-month figure less the 6-month figure.Report this figure9.9Capital expenditure, Q4 FY2023, three months to 2023-12-31$9.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-27, accession 0001723128-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure9.2Capital expenditure, Q1 FY2024, three months to 2024-03-31$9.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-07, accession 0001723128-25-000022.Report this figure10.6Capital expenditure, Q2 FY2024, three months to 2024-06-30$10.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0001723128-25-000047. Derived: 6-month figure less the 3-month figure.Report this figure16.9Capital expenditure, Q3 FY2024, three months to 2024-09-30$16.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001723128-25-000062. Derived: 9-month figure less the 6-month figure.Report this figure15.2Capital expenditure, Q4 FY2024, three months to 2024-12-31$15.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-27, accession 0001723128-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure13.2Capital expenditure, Q1 FY2025, three months to 2025-03-31$13.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure22.8Capital expenditure, Q2 FY2025, three months to 2025-06-30$22.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001723128-26-000031. Derived: 6-month figure less the 3-month figure.Report this figure12.3Capital expenditure, Q3 FY2025, three months to 2025-09-30$12.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001723128-25-000062. Derived: 9-month figure less the 6-month figure.Report this figure21.8Capital expenditure, Q4 FY2025, three months to 2025-12-31$21.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-27, accession 0001723128-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure8.2Capital expenditure, Q1 FY2026, three months to 2026-03-31$8.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure30.7Capital expenditure, Q2 FY2026, three months to 2026-06-30$30.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001723128-26-000031. Derived: 6-month figure less the 3-month figure.Report this figure
Dividends paid$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)328.10m, Q2 FY2026
Amneal Pharmaceuticals, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares151Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30151,393,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0001723128-23-000044.Report this figure152Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31152,109,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-08, accession 0001723128-24-000021.Report this figure155Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30154,887,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-09, accession 0001723128-24-000032.Report this figure160Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30159,691,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0001723128-24-000042.Report this figure307Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31307,279,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-07, accession 0001723128-25-000022.Report this figure319Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30318,957,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0001723128-25-000047.Report this figure310Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30309,647,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001723128-25-000062.Report this figure324Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31323,961,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure322Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30322,363,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure325Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30324,754,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001723128-25-000062.Report this figure329Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31328,933,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001723128-26-000020.Report this figure328Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30328,102,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure

Shares outstanding: 319.35mShares outstanding, period not labelled, at 2026-07-31319,353,919 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001723128-26-000031.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.